SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NTEG- Bloodless Glucose Monitor

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stratajema who wrote (33)9/29/1997 5:49:00 PM
From: Stratajema   of 176
 
To all. No news. Look for price support at $5, the line of marginability for most accounts. IMHO, expect the downward price pressure to continue over the next 45 days due to: 1. end of quarter (9/30/97) escape (failed support at $6.75), 2. Mutual fund portfolio balancing throughout October, 3. TCPI expected to be first to market with their device.

I think the next 3 to 4 months will represent the last opportunity to accumulate Integ at a low price. (I base this comment on my expectation of a design freeze by mid-1998.) I will listen to the quarterly conference call in late October and finalize my accumulation strategy then.

I'm still hoping someone can specifically challenge my remarks about Technical Chemical & Products Inc's (TCPI) technology platform. Four industry insiders I have spoken with are bewildered as to how such a device will work accurately . I believe TCPI's other products are real such as their Health Check line but I believe TCPI proposed a non-invasive glucose device as a means to obtain a much larger amount of funds at their last public offering. Enough said.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext